Postsynaptic Densities
<table class="infobox infobox-celltype">
<tr>
<th class="infobox-header" colspan="2">Postsynaptic Densities (PSDs)</th>
</tr>
<tr>
<td class="label">Lineage</td>
<td>Neuronal compartment > Postsynaptic specialization</td>
</tr>
<tr>
<td class="label">Markers</td>
<td>PSD95 (DLG4), NMDA receptor (GRIN1/2A), AMPA receptor (GRIA1/2), mGluR5, Shank3</td>
</tr>
<tr>
<td class="label">Brain Regions</td>
<td>Dendritic spines of excitatory neurons</td>
</tr>
<tr>
<td class="label">Disease Vulnerability</td>
<td>[Alzheimer's Disease](/diseases/alzheimers-disease), Schizophrenia, Autism</td>
</tr>
</table>
Postsynaptic Densities (PSDs)
Introduction
Postsynaptic Densities (PSDs) are specialized postsynaptic compartments found at excitatory synapses in the brain. They represent highly organized protein networks that orchestrate synaptic signaling, plasticity, and structural stability. PSDs are primarily located on dendritic spines of excitatory neurons and serve as the primary signaling hub for glutamatergic neurotransmission.
The PSD contains hundreds of proteins organized into layered zones: a membrane-associated guanylate kinase (MAGUK) scaffold centered on PSD95 organizes NMDA receptors and associated signaling molecules at the core, while AMPA receptors are positioned more peripherally. This organization enables precise temporal and spatial control of synaptic transmission.
Overview
...Postsynaptic Densities
<table class="infobox infobox-celltype">
<tr>
<th class="infobox-header" colspan="2">Postsynaptic Densities (PSDs)</th>
</tr>
<tr>
<td class="label">Lineage</td>
<td>Neuronal compartment > Postsynaptic specialization</td>
</tr>
<tr>
<td class="label">Markers</td>
<td>PSD95 (DLG4), NMDA receptor (GRIN1/2A), AMPA receptor (GRIA1/2), mGluR5, Shank3</td>
</tr>
<tr>
<td class="label">Brain Regions</td>
<td>Dendritic spines of excitatory neurons</td>
</tr>
<tr>
<td class="label">Disease Vulnerability</td>
<td>[Alzheimer's Disease](/diseases/alzheimers-disease), Schizophrenia, Autism</td>
</tr>
</table>
Postsynaptic Densities (PSDs)
Introduction
Postsynaptic Densities (PSDs) are specialized postsynaptic compartments found at excitatory synapses in the brain. They represent highly organized protein networks that orchestrate synaptic signaling, plasticity, and structural stability. PSDs are primarily located on dendritic spines of excitatory neurons and serve as the primary signaling hub for glutamatergic neurotransmission.
The PSD contains hundreds of proteins organized into layered zones: a membrane-associated guanylate kinase (MAGUK) scaffold centered on PSD95 organizes NMDA receptors and associated signaling molecules at the core, while AMPA receptors are positioned more peripherally. This organization enables precise temporal and spatial control of synaptic transmission.
Overview
Postsynaptic Densities (PSDs) are a specialized cell type classified within the Neuronal compartment > Postsynaptic specialization lineage. These cells are primarily found in Dendritic spines of excitatory neurons and are characterized by expression of marker genes including PSD95 (DLG4), NMDA receptor (GRIN1/2A), AMPA receptor (GRIA1/2), mGluR5. They are selectively vulnerable in Alzheimer's Disease, Schizophrenia, Autism.
Molecular Organization
The PSD consists of multiple protein families organized into functional modules:
Core Scaffold Proteins
- PSD95 (DLG4): The major scaffolding protein that clusters NMDA receptors and links them to downstream signaling molecules
- Shank3: Connects PSD95 to the actin cytoskeleton, providing structural stability
- Homer: Links metabotropic glutamate receptors to downstream effectors
Glutamate Receptors
- NMDA Receptors (GRIN1/2A/2B): Calcium-permeable channels essential for synaptic plasticity
- AMPA Receptors (GRIA1-4): Fast excitatory neurotransmission mediators
- mGluR5: Group I metabotropic glutamate receptor involved in calcium signaling
Associated Signaling Molecules
- CaMKII: Calcium/calmodulin-dependent protein kinase II, critical for LTPmechanisms/long-term-potentiation)
- Ras GTPases: Regulate AMPA receptor trafficking
- PI3K/Akt pathway: Involved in synaptic plasticity and cell survival
Morphology and Markers
Postsynaptic Densities (PSDs) are identified by the expression of the following key marker genes:
- PSD95 (DLG4)
- NMDA receptor (GRIN1/2A)
- AMPA receptor (GRIA1/2)
- mGluR5
- Shank3
These markers are used for immunohistochemical identification and single-cell RNA sequencing classification, as catalogued in the [Allen Cell Type Atlas](https://portal.brain-map.org/atlases-and-data/rnaseq).
Normal Function
Postsynaptic Densities (PSDs) play essential roles in neural circuits and brain function. They are found in the following brain regions:
- Dendritic spines of excitatory neurons
Their normal functions include:
Synaptic Transmission
PSDs receive glutamatergic input and convert it into postsynaptic electrical and biochemical signals. The tight clustering of receptors ensures high-sensitivity detection of neurotransmitter release.
Synaptic Plasticity
PSDs are central to learning and memory processes. Long-term potentiation (LTP) and long-term depression (LTD) involve dynamic remodeling of PSD composition, including:
- AMPA receptor insertion/removal
- PSD95 palmitoylation changes
- CaMKII autophosphorylation
Structural Stability
The PSD links to the actin cytoskeleton via Shank proteins, maintaining dendritic spine morphology essential for proper synaptic connectivity.
Vulnerability in Disease
Postsynaptic Densities (PSDs) show selective vulnerability in the following neurodegenerative conditions:
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- Schizophrenia
- Autism
Alzheimer's Disease
In AD, PSDs undergo significant alterations:
- NMDA receptor dysfunction: Reduced surface expression and impaired signaling
- PSD95 loss: Correlates with cognitive decline
- AMPA receptor trafficking deficits: Contribute to synaptic failure
- CaMKII dysregulation: Impairs LTP induction
The amyloid-beta oligomers directly bind to NMDA receptors, causing internalization and disrupting synaptic plasticity mechanisms. Tau pathology also targets PSD components, leading to synaptic loss.
The selective vulnerability of these cells is an active area of research, with factors including metabolic demands, calcium handling, exposure to toxic protein aggregates, and cell-autonomous gene expression programs contributing to their susceptibility.
Transcriptomic Profile
Single-cell and single-nucleus RNA sequencing studies have revealed the transcriptomic signature of Postsynaptic Densities (PSDs). Key differentially expressed genes from the Allen Cell Type Atlas and related datasets include the marker genes listed above. These transcriptomic profiles help identify subtypes and disease-associated gene expression changes.
Key Publications
[Molecular organization of the postsynaptic density](https://doi.org/10.1038/s41583-020-0333-7). Nat Rev Neurosci, 2020.
[PSD-95 and synaptic plasticity](https://doi.org/10.1016/j.neuron.2019.12.003). Neuron, 2020.
[Alzheimer's disease and synaptic dysfunction](https://doi.org/10.1038/s41582-019-0199-8). Nat Rev Neurol, 2019.
External Links
- Allen Cell Type Atlas: [https://portal.brain-map.org/atlases-and-data/rnaseq](https://portal.brain-map.org/atlases-and-data/rnaseq)
- Allen Human Brain Atlas: [https://human.brain-map.org/](https://human.brain-map.org/)
- [Cell Types Index](/cell-types/cell-types)
- [Genes Index](/genes/genes)
- [Diseases Index](/diseases/diseases)
- [Mechanisms Index](/mechanisms) [NMDA Receptor](/proteins/nmda-receptor)
- [AMPA Receptor](/proteins/ampa-receptor)
- [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
- [--](/proteins/n--cadherin-protein)
Background
The study of Postsynaptic Densities has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.